Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors in the central anxious system, conolidine modulates alternate molecular targets. A Science Improvements research uncovered that conolidine interacts Together with the atypical chemokine receptor ACKR3/CXCR7, w